Abstract
Concurrent chemoradiation (CRT) is commonly used to treat advanced stage oropharyngeal cancer (OPC). CRT affects the immune system, but the specific effects on immune cell populations and function during and after treatment are poorly defined. This study was performed to assess the impact of CRT on T cell populations and their function during and after treatment in patients with advanced stage OPC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
